拜耳(BAYRY)
搜索文档
Bayer(BAYRY) - 2021 Q2 - Earnings Call Transcript
2021-08-06 02:30
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q2 2021 Earnings Conference Call August 5, 2021 8:00 AM ET Company Participants Oliver Maier - Head-Investor Relations Werner Baumann - Chief Executive Officer Wolfgang Nickl - Chief Financial Officer Stefan Oelrich - President-Pharmaceuticals Division Liam Condon - President Crop Science Division Conference Call Participants Michael Leuchten – UBS Vincent Andrews – Morgan Stanley Joel Jackson – BMO Jo Walton – Credit Suisse James Quigley – Morgan Stanley Tony Jones – ...
Bayer(BAYRY) - 2021 Q2 - Earnings Call Presentation
2021-08-05 23:22
| --- | --- | |------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Half-Year | | | Financial Report 2021 | Bayer: Strong growth, guidance upgrade | | | // Group sales at €10.9 billion (Fx & p adj. +12.9%) -- double-digit percentage growth | | | (Fx & p adj.) at all divisions // EBITDA before special items at €2.6 billion (--10.6%), burdened by currency effects ...
Bayer(BAYRY) - 2021 Q1 - Earnings Call Transcript
2021-05-13 02:23
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q1 2021 Earnings Conference Call May 12, 2021 8:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - CEO Wolfgang Nickl - CFO Liam Condon - President, Crop Science Division Stefan Oelrich - Head, Pharmaceuticals Division Conference Call Participants Vincent Andrews - Morgan Stanley Peter Verdult - Citigroup Inc Joel Jackson - BMO Capital Markets Equity Research Christian Faitz - Kepler Cheuvreux Tony Jones - Redburn Laerke Engkilde - ...
Bayer(BAYRY) - 2021 Q1 - Earnings Call Presentation
2021-05-12 23:31
/////////// Investor Conference Call Q1 2021 Results May 12, 2021 Werner Baumann, CEO Wolfgang Nickl, CFO RESTRICTED Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the est ...